II. Indications

III. Dosing

  1. Start 34 mg orally daily
    1. Lower dose to 10 mg daily if on CYP3A4 Inhibitors

V. Drug Interactions

  1. Metabolized by CYP3A4
  2. Avoid with strong CYP3A4 inducers

VI. Adverse Effects

VII. Safety

  1. Unknown safety in pregnancy
  2. Unknown safety in Lactation

IX. References

  1. (2016) Med Lett Drugs Ther 58(1510): 160-5
  2. Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 42-3
  3. Hamilton (2020) Tarascon Pocket Pharmacopoeia

Images: Related links to external sites (from Bing)

Related Studies